Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Opat

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Blood|July 18, 2024
Treatment of relapsed CLL "in the BAAG"?Stephen Opat
Future Oncology (London, England)|October 16, 2020
An update of venetoclax and obinutuzumab in chronic lymphocytic leukemiaRoss Salvaris, Stephen Opat
Future Oncology (London, England)|September 11, 2025
Zanubrutinib in the treatment of Waldenström MacroglobulinemiaElizabeth Goodall, Stephen Opat
Blood Advances|August 28, 2025
Too soon to reject immunoglobulin replacement in CLLStephen Opat, Ross Salvaris
British Journal of Haematology|April 14, 2006
An unusual case of indigestion: persistence of phagocytosed Auer rods in acute promyelocytic leukaemiaChristina Brown, Stephen Opat
British Journal of Haematology|May 30, 2024
Large cell lymphoma through a liquid lensJake Shortt, Stephen Opat
Leukemia & Lymphoma|January 29, 2025
Indolent lymphoma: addressing the needs of survivorsPasquale L Fedele, Stephen Opat
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2017
Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life SupportStephen Opat, Eliza A Hawkes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2024
Chronic Lymphocytic Leukemia: Time to Care for the SurvivorsPasquale L Fedele, Stephen Opat
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2020
Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCLEliza A Hawkes, Stephen Opat, Mark Hertzberg
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Blood|July 18, 2024
Treatment of relapsed CLL "in the BAAG"?Stephen Opat
Future Oncology (London, England)|October 16, 2020
An update of venetoclax and obinutuzumab in chronic lymphocytic leukemiaRoss Salvaris, Stephen Opat
Future Oncology (London, England)|September 11, 2025
Zanubrutinib in the treatment of Waldenström MacroglobulinemiaElizabeth Goodall, Stephen Opat
Blood Advances|August 28, 2025
Too soon to reject immunoglobulin replacement in CLLStephen Opat, Ross Salvaris
British Journal of Haematology|April 14, 2006
An unusual case of indigestion: persistence of phagocytosed Auer rods in acute promyelocytic leukaemiaChristina Brown, Stephen Opat
British Journal of Haematology|May 30, 2024
Large cell lymphoma through a liquid lensJake Shortt, Stephen Opat
Leukemia & Lymphoma|January 29, 2025
Indolent lymphoma: addressing the needs of survivorsPasquale L Fedele, Stephen Opat
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2017
Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life SupportStephen Opat, Eliza A Hawkes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2024
Chronic Lymphocytic Leukemia: Time to Care for the SurvivorsPasquale L Fedele, Stephen Opat
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2020
Caution in Expanding the Use of Abbreviated R-CHOP to Poor-Risk Limited-Stage DLBCLEliza A Hawkes, Stephen Opat, Mark Hertzberg
Pageof 13